Acta Pol Pharm / Mayo Clinic Myeloma Group / Finnish Leukaemia Group / Miles AE / Eastern Cooperative Oncology Group / S.R.Z. D.D. / Myeloma Group Consensus Opinion The Mayo Myeloma Group / Genentech Inc. / /
Country
United States / / /
Event
FDA Phase / /
Facility
Mayo Clinic College of Medicine / /
IndustryTerm
cancer therapy / treatment of bone disease / /
MedicalCondition
periodontitis / osteonecrosis / multiple myeloma / epidemic / Multiple myeloma cells / osteoclast-induced bone resorption / Leukaemia / malignant plasma cell disorder / bone resorption / prostate cancer / MS / breast cancer / osteopenia / bony disease / tumor / hypercalcemia malignancy / necrosis / Cancer / tumors / disease / lytic bone disease / Multiple Myeloma MARTHA Q. LACY / chronic / fever / bone disease / pain / renal insufficiency / osteopetrosis / osteoporosis / infection / renal failure / metastases / Fragilitas ossium / /
Food and Drug Administration / Division of Hematology/Oncology / Division of Oral Diagnosis and Oral / Department of Dental Specialties / American Society of Clinical Oncology / Division of Medical Oncology / Mayo Clinic College of Medicine / American Academy / Division of Hematology / Mayo Foundation / /
Person
Sebastian-Lopez C. Osteonecrosis / CHRISTOPHER F. VIOZZI / ALAN B. CARR / EUGENE E. KELLER / ROBERT A. KYLE / ROBERT J. DALTON / STEPHEN J. RUSSELL / MORIE A. GERTZ / RAFAEL FONSECA / DEEPAK KADEMANI / Mayo Clin Proc / P. LIEF BERGSAGEL / DAVID DINGLI / S. VINCENT RAJKUMAR / MARTHA Q. LACY / THOMAS E. WITZIG / CRAIG B. REEDER / VIVEK ROY / Ann Intern Med / SHAJI KUMAR / KIMBERLY L. GOLLBACH / PHILIP R. GREIPP / Ann Oncol / ANGELA DISPENZIERI / A. KEITH STEWART / SUZANNE R. HAYMAN / R. ZELDENRUST / Q. Lacy / /
SPECIAL ARTICLE MAYO CLINIC CONSENSUS STATEMENT FOR BISPHOSPHONATES IN MM Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma